Bravecto does not prevent heartworm. It is an ectoparasiticide, meaning it kills fleas and ticks on the outside of your pet’s body. Heartworm disease is caused by a completely different type of parasite, an internal worm transmitted by mosquitoes, and preventing it requires a separate class of drugs. The confusion is understandable: Bravecto is a powerful, long-lasting anti-parasite product, and many pet owners reasonably assume it covers all parasites. But the gap between what Bravecto targets and what causes heartworm is significant enough that relying on Bravecto alone leaves your dog or cat unprotected against one of the most dangerous parasitic infections they can get.
What Bravecto Actually Kills
Bravecto’s active ingredient is fluralaner, a member of the isoxazoline drug class. It works by blocking specific channels in the nervous systems of arthropods like fleas and ticks, causing paralysis and death in those organisms.1PubMed Central. The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs This mechanism is highly effective against creatures with exoskeletons, but it has no meaningful activity against heartworm larvae or adult heartworms, which are nematodes (roundworms) with entirely different biology.
One of Bravecto’s selling points is its dosing schedule. While most flea and tick products require monthly application, Bravecto’s chewable tablet for dogs provides protection for about 12 weeks per dose.2PubMed Central. A comparative analysis of heartworm medication use patterns for dogs that also receive ectoparasiticides That convenience factor is a real advantage for pet owners who struggle to stay on schedule with monthly treatments. But the 12-week interval applies only to flea and tick control. Heartworm prevention still has to be handled separately, usually with a monthly product.
Why Heartworm Needs a Different Drug Entirely
Heartworm disease is caused by Dirofilaria immitis, a parasitic worm that can grow up to a foot long inside a dog’s heart and pulmonary arteries. Mosquitoes transmit microscopic larvae when they bite, and those larvae migrate through the dog’s body over several months before maturing into adults that lodge in the cardiovascular system. Preventing this infection means killing the larvae during the early stages of migration, before they reach the heart.
The drugs that accomplish this belong to a class called macrocyclic lactones, which includes ivermectin, milbemycin oxime, moxidectin, and selamectin. These compounds kill the third- and fourth-stage larvae of Dirofilaria immitis, stopping the worms before they can develop into adults.3PubMed Central. A review of moxidectin vs. other macrocyclic lactones for prevention of heartworm disease in dogs with an appraisal of two commercial formulations Fluralaner, the active ingredient in Bravecto, is not a macrocyclic lactone. It belongs to an entirely different chemical family and targets an entirely different set of organisms. There is no overlap in what these two drug classes do, which is why no amount of Bravecto will substitute for a heartworm preventive.
The One Exception: Bravecto Plus for Cats
If you’ve heard someone say Bravecto does cover heartworm, they might be thinking of Bravecto Plus, a topical formulation available for cats. Bravecto Plus combines fluralaner with moxidectin, the latter being one of those macrocyclic lactones that kills heartworm larvae.4Parasites & Vectors. Efficacy of two topical fluralaner formulations (Bravecto® and Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats So Bravecto Plus does provide heartworm prevention in cats, but only because of the added moxidectin. The fluralaner component still handles only the flea and tick side of things.
This distinction matters because there is no equivalent Bravecto Plus product for dogs. Dog owners using Bravecto chewable tablets or Bravecto topical spot-on are getting flea and tick protection and nothing more in the heartworm department. If your cat is on Bravecto Plus, you’re covered on both fronts. If your dog is on Bravecto, you need a separate heartworm preventive.
Can You Safely Use Bravecto With a Heartworm Preventive?
Yes, and most veterinarians expect you to. A pharmacokinetic study found that giving fluralaner alongside ivermectin (one of the most common heartworm preventive ingredients) did not change how either drug was absorbed or processed in dogs.5BioMed Central / Parasites & Vectors. Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs Blood levels of both drugs remained the same whether given alone or together. In practical terms, Bravecto won’t interfere with your dog’s heartworm pill, and vice versa.
An interesting side effect of Bravecto’s longer dosing interval is that it may actually help pet owners stay more consistent with their heartworm prevention. Research comparing medication purchase patterns found that the 12-week Bravecto schedule appeared to correlate with how many heartworm doses owners purchased over a year, prompting investigation into whether a simpler flea-and-tick regimen freed up mental bandwidth for remembering the monthly heartworm pill.2PubMed Central. A comparative analysis of heartworm medication use patterns for dogs that also receive ectoparasiticides Compliance with heartworm preventives is a real and widespread problem. One economic analysis noted that the American Heartworm Society estimates treatment for a dog already diagnosed with heartworm costs roughly $1,200 to $1,800, making consistent monthly prevention far cheaper than dealing with an active infection.6Frontiers in Veterinary Science. Pharmacoeconomic Analysis of Heartworm Preventive Compliance and Revenue in Veterinary Practices in the United States
What Else Bravecto Covers Beyond Fleas and Ticks
While Bravecto won’t help with heartworm, it does have a broader reach than some pet owners realize when it comes to external parasites. Beyond standard flea and tick infestations, fluralaner has shown strong efficacy against sarcoptic mange, a skin disease caused by burrowing mites. In a field study of pet dogs with confirmed sarcoptic mange, a single treatment with either chewable or topical fluralaner eliminated mites completely and maintained that effect for 12 weeks.7PubMed Central. Efficacy of orally and topically administered fluralaner (Bravecto®) for treatment of client-owned dogs with sarcoptic mange under field conditions An earlier study confirmed the same pattern: a single dose produced a complete reduction in mite counts, with visible improvement in symptoms like crusty skin and hair loss over the following weeks.8PubMed Central. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs
Bravecto’s rapid tick-killing speed also gives it an indirect protective role against tick-borne diseases like Lyme disease, anaplasmosis, and ehrlichiosis. Ticks need to feed for a period of time before they can transmit pathogens, and fluralaner kills ticks fast enough after attachment to substantially reduce that risk. Studies show an almost complete killing effect within 12 hours of tick infestation throughout the full 12-week protection window.1PubMed Central. The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs This is a meaningful benefit because tick-borne diseases can be debilitating and expensive to treat. But again, tick-borne disease and heartworm disease are entirely separate problems caused by entirely separate organisms, and the protection Bravecto offers against one does nothing for the other.
A Note on Isoxazoline Safety
Since we’re talking about what Bravecto does and doesn’t do, it’s worth addressing something that comes up in nearly every online discussion about the product: safety concerns. Fluralaner belongs to the isoxazoline class, which also includes sarolaner (Simparica), afoxolaner (NexGard), and lotilaner (Credelio). In 2018, the U.S. FDA issued an alert noting the potential for neurological side effects in dogs and cats treated with isoxazoline products, including tremors, unsteadiness, and seizures.9PubMed Central. Survey of canine use and safety of isoxazoline parasiticides The FDA subsequently required updated labeling across the entire isoxazoline class to highlight these events.
Context matters here. These neurological events appear to be uncommon relative to the number of dogs and cats treated with isoxazolines worldwide, and the products remain FDA-approved and widely recommended by veterinarians. Dogs with a history of seizures or neurological conditions may warrant extra caution, and that’s a conversation to have with your vet. But these safety concerns are about the flea-and-tick function of Bravecto. They do not change the heartworm picture at all, because Bravecto doesn’t touch heartworm in the first place.
The Growing Problem of Heartworm Resistance
One reason it’s especially important not to skip or substitute your heartworm preventive is that the parasites themselves are evolving. Loss of efficacy of macrocyclic lactone preventives against heartworm was first reported in the mid-2000s, and proof of genuine drug resistance in certain heartworm populations in the United States was confirmed about a decade later.10Elsevier / International Journal for Parasitology. Macrocyclic lactone resistance in Dirofilaria immitis: risks for prevention of heartworm disease Some researchers have raised alarm that continued reliance on macrocyclic lactones alone, particularly when they fail against resistant strains, may further spread resistant genotypes. Strategies like using higher-dose moxidectin formulations and adding mosquito repellents to the prevention protocol are being explored to slow this trend.
For pet owners, the takeaway is that heartworm prevention, while still overwhelmingly effective, is not something to be cavalier about. Consistent year-round dosing, annual testing, and following your veterinarian’s specific product recommendation all matter more now than they might have 20 years ago. If your dog’s only parasite protection is Bravecto, it has zero heartworm coverage, and in a world where some heartworm populations are developing resistance to the drugs that do work, that gap is not one you want to leave open.
Heartworm in Cats Is a Different Beast
Most heartworm conversations focus on dogs, but cats are also susceptible, and the disease plays out very differently in felines. Heartworm infection in cats is described by veterinary specialists as a diagnostic and therapeutic puzzle because clinical signs can be absent or look nothing like what veterinarians expect.11PubMed. Feline heartworm disease: A ‘Rubik’s-cube-like’ diagnostic and therapeutic challenge No single blood test reliably detects heartworm in cats, so diagnosis usually requires combining several tests with imaging. Making matters worse, the adulticide treatment used in dogs (melarsomine) is not safe for cats. Treatment in cats is limited to managing symptoms because killing adult worms in a cat’s smaller cardiovascular system carries unacceptable risk.12PubMed. Understanding feline heartworm infection: disease, diagnosis, and treatment
This is actually where the Bravecto Plus formulation for cats becomes particularly valuable. Because heartworm in cats is so difficult to diagnose and essentially impossible to cure safely, prevention is the only reliable strategy. If your cat is already on Bravecto Plus, the included moxidectin handles heartworm prevention alongside the flea and tick coverage from fluralaner. Cat owners using standard Bravecto (without the “Plus”) still need a separate heartworm preventive, just as dog owners do.
How Ticks Absorb Fluralaner
An interesting detail about how Bravecto works against ticks involves just how little of the drug a tick needs to ingest before dying. Researchers measured tick weights and a measurement called the coxal index to assess how much blood ticks had consumed from treated versus untreated dogs. The findings confirmed that only minimal blood uptake by a tick was enough for fluralaner to reach lethal concentrations in the tick’s system.13PubMed Central. A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto) treated vs. untreated dogs using the parameters tick weight and coxal index This helps explain both why Bravecto kills ticks so quickly after they attach and why the protection persists for the full 12-week duration without the drug needing to reach especially high systemic concentrations in the dog. It’s an elegant design for killing ectoparasites, but it underscores the product’s limitations: fluralaner is distributed through the bloodstream at concentrations tuned to kill arthropods, not nematode larvae migrating through tissue on their way to the heart.